Lou Kennedy and Sam Konduros Published 11:51 a.m. ET Oct. 18, 2020

Patients in the US have faced drug shortages for years. This was illustrated amid the current pandemic, which was exacerbated by shortages of PPE (personal protective equipment), testing ingredients and drugs required for COVID-19 treatment. 

Although America remains the world’s top innovator in life sciences, it dramatically lags countries such as China and India in the manufacture of antibiotics, active pharmaceutical ingredients formulated into tablets, capsules and medicines (API), vitamin C, many medical devices, and PPE.

While South Carolina reaps extraordinary benefits from foreign investment by international manufacturers, returning the manufacturing and sourcing of life sciences products to our country and state is not only a powerful economic driver – it’s a path to

Read More At Article Source | Article Attribution